[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Eastern Cranial Affiliates, Eminent Spine, Fasprin Health/Nobel Laboratories, HS...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on Reports of Corrections and Removals 21 CFR Part 806.[ Price : $8.95]
Federal Register Notice: FDA amends the notice of a 12/2 meeting of the Oncologic Drugs Advisory Committee to postpone a discussio...[ Price : $8.95]
A federal appeals court rejects a Vermont law that tried to restrict health information company access to prescribing information.[ Price : $8.95]
Merck says it will seek FDA approval to expand the use of its cholesterol-lowering drug Vytorin for patients with kidney disease a...[ Price : $8.95]
The U.S. Justice Department says fiscal year 2010 saw a record $1.8 billion in fines, forfeitures, and related actions under the F...[ Price : $8.95]
Daiichi Sankyo and Genzyme file a patent infringement suit against Impax Laboratories over a recently submittied ANDA for a generi...[ Price : $8.95]
Omthera Pharmaceuticals and FDA reach agreement on a special protocol assessment on a planned Phase 3 trial involving Epanova for ...